Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Sanofi Pasteur Poised For Restructuring

by Alex Scott
July 16, 2012 | A version of this story appeared in Volume 90, Issue 29

Sanofi Pasteur, the France-based vaccines subsidiary of Sanofi, is about to be restructured to improve its profitability. The company is set to introduce measures to enhance the performance of its manufacturing activities and support functions. Sanofi says that it has begun talks with workers’ representatives about the plan but that no specific job cut numbers have been proposed. The French newspaper Le Figaro reports that the restructuring will lead to the loss of 2,000 jobs across France.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.